KEGG   PATHWAY: sbq05150
Entry
sbq05150                    Pathway                                
Name
Staphylococcus aureus infection - Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
Description
Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.
Class
Human Diseases; Infectious disease: bacterial
Pathway map
sbq05150  Staphylococcus aureus infection
sbq05150

Organism
Saimiri boliviensis boliviensis (Bolivian squirrel monkey) [GN:sbq]
Gene
104650642  LOW QUALITY PROTEIN: uncharacterized protein LOC104650642 [KO:K07604]
101049160  keratin, type I cuticular Ha3-I-like [KO:K07604]
101052560  KRT32; keratin, type I cuticular Ha2 [KO:K07604]
101051584  KRT38; keratin, type I cuticular Ha8 [KO:K07604]
101053509  KRT37; keratin, type I cuticular Ha7 [KO:K07604]
101051905  KRT34; keratin, type I cuticular Ha4 [KO:K07604]
101054476  keratin, type I cuticular Ha3-I [KO:K07604]
101054151  KRT40; keratin, type I cytoskeletal 40 [KO:K07604]
101054475  KRT39; keratin, type I cytoskeletal 39 [KO:K07604]
101053508  KRT23; keratin, type I cytoskeletal 23 [KO:K07604]
101027642  KRT20; keratin, type I cytoskeletal 20 [KO:K07604]
101050948  KRT12; keratin, type I cytoskeletal 12 [KO:K07604]
101032500  KRT28; keratin, type I cytoskeletal 28 [KO:K07604]
101032175  KRT27; keratin, type I cytoskeletal 27 [KO:K07604]
101032821  KRT26; keratin, type I cytoskeletal 26 [KO:K07604]
101033141  KRT25; keratin, type I cytoskeletal 25 [KO:K07604]
101033459  KRT24; keratin, type I cytoskeletal 24 [KO:K07604]
101047109  KRT18; keratin, type I cytoskeletal 18 [KO:K07604]
101053823  KRT17; keratin, type I cytoskeletal 17 [KO:K07604]
101053197  KRT16; keratin, type I cytoskeletal 16 isoform X2 [KO:K07604]
101050083  KRT14; keratin, type I cytoskeletal 14 [KO:K07604]
101027947  KRT19; keratin, type I cytoskeletal 19 [KO:K07604]
101052875  KRT15; keratin, type I cytoskeletal 15 [KO:K07604]
101050414  KRT13; keratin, type I cytoskeletal 13 isoform X1 [KO:K07604]
101051265  KRT36; keratin, type I cuticular Ha6 [KO:K07604]
101052222  KRT35; keratin, type I cuticular Ha5 [KO:K07604]
101053198  KRT9; keratin, type I cytoskeletal 9 [KO:K07604]
101053824  LOW QUALITY PROTEIN: keratin, type I cuticular Ha7-like [KO:K07604]
101054152  KRT31; keratin, type I cuticular Ha1 [KO:K07604]
104650055  keratin, type I cuticular Ha3-I-like [KO:K07604]
101029866  KRT10; keratin, type I cytoskeletal 10 [KO:K07604]
101043315  FGG; fibrinogen gamma chain [KO:K03905]
101044671  C3; complement C3 [KO:K03990]
101036079  CFB; complement factor B [KO:K01335] [EC:3.4.21.47]
101030841  CFD; complement factor D [KO:K01334] [EC:3.4.21.46]
101044777  complement factor H isoform X1 [KO:K04004]
101029843  mannose-binding protein A-like [KO:K03991]
101045108  MBL2; mannose-binding protein C [KO:K03991]
101033147  MASP1; mannan-binding lectin serine protease 1 isoform X1 [KO:K03992] [EC:3.4.21.-]
101047723  MASP2; mannan-binding lectin serine protease 2 isoform X1 [KO:K03993] [EC:3.4.21.104]
101040997  LOW QUALITY PROTEIN: putative V-set and immunoglobulin domain-containing protein 7 [KO:K06856]
101054381  putative V-set and immunoglobulin domain-containing-like protein IGHV1OR21-1 [KO:K06856]
101033685  uncharacterized protein LOC101033685 [KO:K06856]
101041646  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 [KO:K06856]
101048882  C1QA; complement C1q subcomponent subunit A [KO:K03986]
101049399  C1QB; complement C1q subcomponent subunit B [KO:K03987]
101048354  C1QC; complement C1q subcomponent subunit C [KO:K03988]
101033061  C1R; complement C1r subcomponent isoform X2 [KO:K01330] [EC:3.4.21.41]
101034947  C1S; complement C1s subcomponent [KO:K01331] [EC:3.4.21.42]
104650316  C2; complement C2 [KO:K01332] [EC:3.4.21.43]
101045782  C4A; complement C4-A [KO:K03989]
101040214  C5; complement C5 [KO:K03994]
101038526  C3AR1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
101034910  C5AR1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
101027415  LOW QUALITY PROTEIN: high affinity immunoglobulin gamma Fc receptor I-like [KO:K06498]
101040113  FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a isoform X1 [KO:K06472]
101039367  FCGR2B; low affinity immunoglobulin gamma Fc region receptor II-b isoform X2 [KO:K12560]
101040447  low affinity immunoglobulin gamma Fc region receptor III isoform X2 [KO:K06463]
101052887  FCAR; immunoglobulin alpha Fc receptor [KO:K06513]
101040239  FPR3; N-formyl peptide receptor 3 [KO:K04173]
101040875  FPR2; N-formyl peptide receptor 2 [KO:K04173]
101028314  plasminogen [KO:K01315] [EC:3.4.21.7]
101045793  CFI; complement factor I isoform X1 [KO:K01333] [EC:3.4.21.45]
101034747  SELPLG; P-selectin glycoprotein ligand 1 [KO:K06544]
101049034  SELP; P-selectin [KO:K06496]
101054438  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
101049788  ITGAL; integrin alpha-L [KO:K05718]
101035688  ITGAM; integrin alpha-M isoform X1 [KO:K06461]
101053620  ITGB2; integrin beta-2 [KO:K06464]
101047470  beta-defensin 4A-like [KO:K21100]
101047788  beta-defensin 103 [KO:K23126]
101046624  neutrophil defensin 1-like isoform X2 [KO:K05230]
101047148  defensin-5 [KO:K05230]
101049999  neutrophil defensin 4 [KO:K05230]
104650356  theta defensin subunit A-like [KO:K05230]
104650357  defensin-5-like [KO:K05230]
101050964  theta defensin subunit A-like [KO:K05230]
101039558  CAMP; cathelicidin antimicrobial peptide [KO:K13916]
101035746  DSG1; desmoglein-1 [KO:K07596]
101031681  uncharacterized protein LOC101031681 [KO:K10785]
101053828  HLA class II histocompatibility antigen, DQ beta 1 chain-like isoform X2 [KO:K06752]
101054155  HLA class II histocompatibility antigen, DQ alpha 1 chain-like [KO:K06752]
101053201  HLA class II histocompatibility antigen, DQ beta 1 chain isoform X4 [KO:K06752]
101054478  HLA class II histocompatibility antigen, DQ alpha 2 chain isoform X1 [KO:K06752]
101052879  HLA class II histocompatibility antigen, DRB1-4 beta chain-like [KO:K06752]
101034517  HLA class II histocompatibility antigen, DRB1-4 beta chain-like isoform X1 [KO:K06752]
101041326  HLA class II histocompatibility antigen, DRB1-4 beta chain-like [KO:K06752]
101034208  HLA class II histocompatibility antigen, DRB1-9 beta chain-like [KO:K06752]
101041640  mamu class II histocompatibility antigen, DR alpha chain [KO:K06752]
101038711  HLA class II histocompatibility antigen, DM beta chain isoform X1 [KO:K06752]
104650606  HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
101039757  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
101039220  HLA class II histocompatibility antigen, DP beta 1 chain [KO:K06752]
101040088  HLA class II histocompatibility antigen, DP alpha 1 chain isoform X1 [KO:K06752]
101052651  HLA class II histocompatibility antigen, DQ beta 2 chain-like [KO:K06752]
101052977  H-2 class II histocompatibility antigen, E-S beta chain-like [KO:K06752]
101039470  PTAFR; platelet-activating factor receptor [KO:K04279]
101052580  IL10; interleukin-10 [KO:K05443]
Compound
C11596  FMLP
C20898  Lipoteichoic acid
Reference
  Authors
Foster TJ
  Title
Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
  Journal
Vet Dermatol 20:456-70 (2009)
DOI:10.1111/j.1365-3164.2009.00825.x
Reference
  Authors
Foster TJ
  Title
Immune evasion by staphylococci.
  Journal
Nat Rev Microbiol 3:948-58 (2005)
DOI:10.1038/nrmicro1289
Reference
  Authors
Laarman A, Milder F, van Strijp J, Rooijakkers S
  Title
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
  Journal
J Mol Med 88:115-20 (2010)
DOI:10.1007/s00109-009-0572-y
Reference
  Authors
Rooijakkers SH, van Kessel KP, van Strijp JA
  Title
Staphylococcal innate immune evasion.
  Journal
Trends Microbiol 13:596-601 (2005)
DOI:10.1016/j.tim.2005.10.002
Reference
  Authors
Iwatsuki K, Yamasaki O, Morizane S, Oono T
  Title
Staphylococcal cutaneous infections: invasion, evasion and aggression.
  Journal
J Dermatol Sci 42:203-14 (2006)
DOI:10.1016/j.jdermsci.2006.03.011
Reference
  Authors
Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM
  Title
Superantigens: the good, the bad, and the ugly.
  Journal
Exp Biol Med (Maywood) 226:164-76 (2001)
DOI:10.1177/153537020122600303
Reference
  Authors
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM
  Title
S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
  Journal
Mol Immunol 45:1600-11 (2008)
DOI:10.1016/j.molimm.2007.10.021
Reference
  Authors
Silverman GJ, Goodyear CS
  Title
Confounding B-cell defences: lessons from a staphylococcal superantigen.
  Journal
Nat Rev Immunol 6:465-75 (2006)
DOI:10.1038/nri1853
Reference
  Authors
Goodyear CS, Silverman GJ
  Title
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  Journal
Proc Natl Acad Sci U S A 101:11392-7 (2004)
DOI:10.1073/pnas.0404382101
Reference
  Authors
Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF
  Title
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
  Journal
PLoS Pathog 4:e1000250 (2008)
DOI:10.1371/journal.ppat.1000250
Reference
  Authors
Bokarewa MI, Jin T, Tarkowski A
  Title
Staphylococcus aureus: Staphylokinase.
  Journal
Int J Biochem Cell Biol 38:504-9 (2006)
DOI:10.1016/j.biocel.2005.07.005
Reference
  Authors
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA
  Title
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
  Journal
Nat Immunol 6:920-7 (2005)
DOI:10.1038/ni1235
Reference
  Authors
Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P
  Title
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
  Journal
Nat Immunol 10:721-7 (2009)
DOI:10.1038/ni.1756
Reference
  Authors
Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH
  Title
Staphylococcal complement evasion by various convertase-blocking molecules.
  Journal
J Exp Med 204:2461-71 (2007)
DOI:10.1084/jem.20070818
Reference
  Authors
Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM
  Title
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
  Journal
J Infect Dis 198:125-33 (2008)
DOI:10.1086/588825
Reference
  Authors
Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ
  Title
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
  Journal
FEMS Microbiol Lett 258:290-6 (2006)
DOI:10.1111/j.1574-6968.2006.00229.x
Reference
  Authors
Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR
  Title
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
  Journal
Proc Natl Acad Sci U S A 107:3681-6 (2010)
DOI:10.1073/pnas.0910565107
Reference
  Authors
Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD
  Title
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
  Journal
Proc Natl Acad Sci U S A 104:15051-6 (2007)
DOI:10.1073/pnas.0706028104
Reference
  Authors
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA
  Title
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
  Journal
J Exp Med 199:687-95 (2004)
DOI:10.1084/jem.20031636
Reference
  Authors
Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP
  Title
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
  Journal
J Immunol 177:8017-26 (2006)
DOI:10.4049/jimmunol.177.11.8017
Reference
  Authors
Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ
  Title
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
  Journal
Blood 109:2936-43 (2007)
DOI:10.1182/blood-2006-06-015461
Reference
  Authors
Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD
  Title
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
  Journal
Mol Microbiol 66:1342-55 (2007)
DOI:10.1111/j.1365-2958.2007.05989.x
Reference
  Authors
Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT
  Title
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.
  Journal
Nat Med 8:687-93 (2002)
DOI:10.1038/nm728
Reference
  Authors
Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M
  Title
Gram-positive three-component antimicrobial peptide-sensing system.
  Journal
Proc Natl Acad Sci U S A 104:9469-74 (2007)
DOI:10.1073/pnas.0702159104
Reference
  Authors
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J
  Title
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
  Journal
Antimicrob Agents Chemother 48:4673-9 (2004)
DOI:10.1128/AAC.48.12.4673-4679.2004
Reference
  Authors
Fraser JD, Proft T
  Title
The bacterial superantigen and superantigen-like proteins.
  Journal
Immunol Rev 225:226-43 (2008)
DOI:10.1111/j.1600-065X.2008.00681.x
Reference
  Authors
Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M
  Title
Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
  Journal
Infect Immun 70:5835-45 (2002)
DOI:10.1128/IAI.70.10.5835-5845.2002
Reference
  Authors
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J
  Title
Human beta-defensins.
  Journal
Cell Mol Life Sci 63:1294-313 (2006)
DOI:10.1007/s00018-005-5540-2
Reference
  Authors
Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB
  Title
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
  Journal
J Clin Invest 115:2855-61 (2005)
DOI:10.1172/JCI25429
Reference
  Authors
Lehrer RI
  Title
Primate defensins.
  Journal
Nat Rev Microbiol 2:727-38 (2004)
DOI:10.1038/nrmicro976
Related
pathway
sbq04610  Complement and coagulation cascades
sbq04660  T cell receptor signaling pathway
sbq04662  B cell receptor signaling pathway
KO pathway
ko05150   
LinkDB

DBGET integrated database retrieval system